Retrospective French Registry of Cardiovascular Magnetic Resonance Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Enrollment
- 5,000
- Primary Endpoint
- To build a score using the "LGE granularity" concept for all-cause mortality prediction in HCM patients.
Study Overview
Brief Summary
This study aims to create a registry of patients with hypertrophic cardiomyopathy, a condition characterized by excessive thickening of the heart muscle. This disease can sometimes lead to serious complications. Currently, the prognosis of these patients is mainly determined by clinical and echocardiographic parameters. Detection of myocardial fibrosis using cardiac MRI enables better risk stratification for these patients.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Age ≥ 18 years
- •Ability to provide informed consent
- •HCM diagnosis referred for CMR assessment.
Exclusion Criteria
- •Patients unable to provide informed consent,
- •Patients with a history of ischemic cardiomyopathy or myocarditis.
Outcomes
Primary Outcomes
To build a score using the "LGE granularity" concept for all-cause mortality prediction in HCM patients.
Time Frame: From Baseline to 5 years
All-cause mortality using the electronic French National Registry of Death (Institut National de la Statistique et des Etudes Economiques, INSEE registry).
Secondary Outcomes
No secondary outcomes reported